Li-Ying Xu (Liying Xu)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Epithelial Mesenchymal Transition

Signaling Pathway

Nitric Oxide Synthase

Top Venues

Evidence-based complementary and alternative medicine : eCAM

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Weiyi Wang, Li-Ying Xu, Lingming Zhou, Shanhong Wan, Libin Jiang
Dioscorea nipponica Makino Relieves Ovalbumin-Induced Asthma in Mice through Regulating RKIP-Mediated Raf-1/MEK/MAPK/ERK Signaling Pathway. BioMed research international 2022 (2022)
Weiyi Wang, Li-Ying Xu, Lingming Zhou, Shanhong Wan, Libin Jiang
A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Rhizoma Dioscoreae Nipponicae in the Treatment of Asthma. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Li-Ying Xu, Wan-Ru Cai, Chun-Fang Ma, Qi-Yang Shou, Jing-Li Qian, Turan S Huseyin
Qi-Dong-Huo-Xue-Yin Inhibits Inflammation in Acute Lung Injury in Mice via Toll-Like Receptor 4/Caveolin-1 Signaling. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)